My Life – 12 mg CagriSema
(6 mg Cagrilintide + 6 mg Semaglutide | 2.6 mL pen | 240 clicks total)
Transform Your Metabolism with Dual Hormone Precision
Description
My Life CagriSema 12 mg is a dual-agonist metabolic peptide that combines two powerful hormones — Cagrilintide (an amylin analogue) and Semaglutide (a GLP-1 receptor agonist) — working synergistically to deliver breakthrough results in appetite control, fat loss, and glucose regulation.
Cagrilintide slows gastric emptying and enhances satiety, while Semaglutide boosts insulin sensitivity and suppresses hunger signals. Together, they deliver amplified and sustained weight-management effects, helping users achieve superior metabolic outcomes compared to single-pathway GLP-1 therapy.
Each 2.6 mL pen with 240 clicks provides convenient, consistent, once-weekly dosing.
General Guidelines
- Administration: Inject subcutaneously (under the skin) once weekly, on the same day each week.
- Injection Sites: Abdomen, thigh, or upper arm – rotate sites weekly.
- Storage: Keep refrigerated at 2 – 8 °C (36 – 46 °F). Do not freeze. Protect from light.
- Handling: Allow pen to reach room temperature before use. Discard after 240 clicks.
- Lifestyle Support: For best results, pair My Life CagriSema with a balanced, high-protein, low-glycaemic diet and regular strength + cardiovascular training.
Suggested Dosage Progression
(240 clicks / 2.6 mL pen)
| Week Range | Clicks per Week | Approx. Dose (mg) | Phase / Notes |
|---|---|---|---|
| Weeks 1 – 4 | 5 clicks | 0.25 mg | Start – allow body to adapt |
| Weeks 5 – 8 | 10 clicks | 0.5 mg | Increase – appetite regulation begins |
| Weeks 9 – 12 | 15 clicks | 0.75 mg | Increase – metabolic activation |
| Weeks 13 – 16 | 20 clicks | 1.0 mg | Increase – active fat-loss phase |
| Week 17 + | 24 clicks | 1.2 mg | Maintain – long-term stability |
*Each click equals approximately 0.05 mg total actives (Cagrilintide + Semaglutide). Adjust dose only under professional guidance.
Possible Side Effects
CagriSema is generally well tolerated, with mild and transient effects during titration:
Common:
- Nausea or mild stomach upset
- Early satiety or reduced appetite
- Bloating or mild constipation
- Fatigue or light dizziness
Less Common:
- Heartburn or reflux
- Temporary headache
- Injection-site redness or tenderness
Symptoms usually subside as the body adjusts. Consult a healthcare provider if persistent.
Half-Life
- Semaglutide: ~165 hours (~7 days)
- Cagrilintide: ~90 hours (~4 days)
The combined pharmacology provides smooth, continuous metabolic signaling with once-weekly dosing convenience.
In Summary
My Life CagriSema 12 mg delivers a dual-hormone strategy for advanced weight-management and metabolic optimization.
With consistent use and lifestyle alignment, users can expect:
- Significant and sustained fat loss
- Reduced hunger and cravings
- Improved insulin and glucose control
- Enhanced overall metabolic health and vitality
Unlock the power of dual-agonist fat loss.
👉 Order My Life CagriSema 12 mg today and take control of your metabolism for lasting transformation.
Disclaimer
All My Life Pharma products are intended for laboratory and research purposes only. They are not approved for human consumption, medical use, or therapeutic application. These products are not intended to diagnose, treat, cure, or prevent any disease. Always handle peptides in accordance with proper laboratory safety and research protocols.
